Related Experiment Video
Updated: Aug 9, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
[Hepatic lesion in patients with hepatocerebral dystrophy]
Insights
Hepatocerebral dystrophy (HCD) presents varied liver damage, with hepatic and endocrine variants showing the most severe clinical, biochemical, and immune affections. Viral infections can worsen liver injury in HCD patients.
Area of Science:
- Hepatology
- Neurology
- Genetics
Background:
- Hepatocerebral dystrophy (HCD) is a rare genetic disorder affecting both the liver and brain.
- Understanding the spectrum of hepatic involvement in HCD is crucial for patient management.
Purpose of the Study:
- To investigate the clinical course and duration of hepatic affection in patients with hepatocerebral dystrophy.
- To characterize the different variants of HCD based on clinical presentation and liver pathology.
Main Methods:
- Retrospective analysis of 63 HCD patient records.
- Evaluation of early clinical symptoms, disease onset, liver function tests, liver morphology, immune status, cytokine profiles, and viral hepatitis markers.
Main Results:
- Six HCD variants identified: hepatic (24), endocrine (17), neurological (12), psychoemotional (5), hemolytic (3), and renal (1).
- Hepatic variant showed progressive hepatitis and cirrhosis; others exhibited fibrosis, lipofuscinosis, and fatty liver disease.
- Hepatotropic virus markers (Hepatitis B, C, G, TT) were more common in the hepatic variant. Mild inflammation indicated by elevated aminotransferases, immunoglobulins, and cytokines.
Conclusions:
- Hepatic lesions in HCD are diverse, with the most severe clinical, biochemical, and immunological manifestations observed in hepatic and endocrine variants.
- Neurological, psychoemotional, and hemolytic variants presented with less severe hepatic involvement.
- Hepatotropic viral infections can exacerbate liver damage in HCD, which is primarily caused by copper imbalance.
Aim:
To study hepatic affection in hepatocerebral dystrophy (HCD) regarding clinical course and duration of the disease.
Material And Methods:
The records on 63 HCD patients were studied retrospectively as to early clinical symptoms, onset dynamics, biochemical tests for hepatic function, morphological changes of the liver, immune and cytokine status, markers of hepatotropic viruses.
Results:
Six variants of HCD course were identified: hepatic (24 patients), endocrine (17 patients), neurological (12 patients), psychoemotional (5 patients), hemolytic (3 patients), renal (1 patient). Early hepatitis and hepatic cirrhosis progress were characteristic for the hepatic variant. The other variants were characterized by hepatic fibrosis, lipofuscinosis, fat dystrophy of the liver. Markers of viral hepatitides B, C, G, TT were detected primarily in patients with a hepatic variant of HCD. A moderate rise of aminotransferases, immunoglobulins, cytokines level indicate weak inflammation in hepatic tissue. Disorders in proteins synthesis, hepatic detoxication function reflect changes in the microsomal system and endoplasmic network.
Conclusion:
Hepatic lesions in HCD are different. Clinical, biochemical, morphological activity and immune status affections were most severe in patients with hepatic and endocrine variants of HCD, being the least severe in neurological, psychoemotional and hemolytic variants. Hepatotropic viruses in some patients deteriorate hepatic lesion caused by copper imbalance.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Lysosomal Hydrolases

